Location: Home
  • search
  • go
  • Relate News
  • 3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)
  • 3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha
  • 3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China
  • 3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
  • 3/7/2022Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...
  • 3/7/2022Hutchmed Gets $15M from AstraZeneca as Part of Orpathys Drug Program i...
  • 3/7/2022NHSA Releases Its 2021 Healthcare Security Sector Development Statisti...
  • 3/7/2022NHC Establishes the Pharmacy Management and Drug Therapy Committee
  • 3/7/2022Central Government Report Emphasizes on Nine Healthcare Reform Measure...
  • 3/4/2022Recent Executive Moves
  • 3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
  • 3/3/2022Lesson from China's National Negotiation of Drug Prices in 2021 (NLR)
  • 3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...
  • 3/1/2022Financial-related Company News Digest
  • 3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/23/2022Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration
  • 2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • 2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...
  • 2/21/2022Inter-Provincial Pacts on Bulk-Buying Drugs Are on the Rise in China, ...
  • 2/21/2022Cross-border Medical Data Compliance in New Era of Regulation
  • 2/18/2022Recent Executive Moves
  • 2/17/2022Innovent Ready to Challenge Amgen and Sanofi in PCSK9 Inhibitor Market...
  • 2/17/2022Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
  • 2/17/2022Chinese Pharmaceutical Cross-Border M&A in 2022 (PharmExec)
  • 2/16/2022SciNeuro and Alamar Collaborate to Discover Novel Therapeutic Antibodi...
  • 2/16/2022Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
  • 2/16/2022Information Collection on the 7th VBP Officially Initiated by the JPO
  • Page:76/362 Total number of articles:10841: [First][<<] [74] [75] [76] [77] [78] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group